Using a multiplex immunofluorescence assay, Savelieva et al. [171] analyzed CTCs from 38 patients with invasive BC demonstrating that all CTCs displaying the EMT marker N-Cadherin also presented stemness markers, yet of different subsets regarding CD44, ALDH1 and/or CD133 expression. The gene discussed is CD44; the disease is breast cancer.